Allianz Asset Management GmbH - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$582,000
-60.7%
50,104
-8.9%
0.00%
-50.0%
Q2 2020$1,482,000
+75.8%
54,996
-74.4%
0.00%
+100.0%
Q2 2018$843,000
-17.2%
214,960
-0.6%
0.00%0.0%
Q1 2018$1,018,000
+12.1%
216,203
-1.7%
0.00%0.0%
Q4 2017$908,000
-35.7%
219,862
-1.3%
0.00%0.0%
Q3 2017$1,412,000
-9.1%
222,768
+12.4%
0.00%
-50.0%
Q2 2017$1,553,000
+25.5%
198,116
+6.0%
0.00%
+100.0%
Q1 2017$1,237,000
+32.4%
186,899
+38.9%
0.00%0.0%
Q4 2016$934,000
-34.1%
134,595
-11.6%
0.00%0.0%
Q3 2016$1,418,000
+12.5%
152,181
+11.5%
0.00%0.0%
Q2 2016$1,261,000136,4510.00%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Defender Capital, LLC. 648,800$1,920,0001.55%
Round Table Services, LLC 339,391$998,0000.31%
ARK Investment Management 3,955,017$11,628,0000.29%
Nikko Asset Management Americas, Inc. 4,884,100$14,359,0000.28%
WASATCH ADVISORS LP 6,735,726$19,803,0000.19%
Cedar Brook Financial Partners, LLC 41,500$122,0000.06%
Unified Trust Company, N.A. 15,716$46,0000.03%
Bay Colony Advisory Group, Inc d/b/a Bay Colony Advisors 13,500$40,0000.03%
STONERIDGE INVESTMENT PARTNERS LLC 16,914$50,0000.02%
Sumitomo Mitsui Trust Holdings, Inc. 4,884,100$14,359,0000.01%
View complete list of INOVIO PHARMACEUTICALS INC shareholders